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N utraceutica Is 
While all agree that the term "nutraceutical" comes from 
the association of the words nutrition and pharmaceuticals, 
it was actually coined in 1989 by Stephen DeFelice, MD, 
founder and chairman of the Foundation for Innovation in 
Medicine (FIM), Cranford, NJ.' According to DeFelice, any 
food or part of food that would provide health benefits 
or prevent and even treat any d isease, mainly chronic 
ones, would be termed nutraceutical. Since then, the word 
became commonly used to include any food, p lants, herbs, 
vitamins, minerals, proteins or other ingredients like pre- or 
probiotics, that would have the aforementioned benefits 
by targeting a substance insufficiency in the body or by 
simply supplementing and increasing the total daily intake 
of a constituent, metabolite, extract or the combination 
of these ingredients.2 However, although nutraceuticals 
would become largely regulated by the different health 
bodies in various countries like the US Food and Drug 
Administration, European Food Safety Authority (EFSA), 
the Chinese SFDA, the Indian FSSA and others, the word 
nutraceutical remains with no regulation definition.3 
REGULATORY FRAMEWORK 
For nutraceuticals manufactured by European nutraceutical 
companies, the manufacturing, marketing and selling of 
end products are mainly overseen by the EFSA, 4 which 
also evaluates the claims associated with these products 
through the Register of Nutrition and Health Claims.5 
Through its foca l points, the EFSA cooperates. with national 
food safety authorities that give EFSA strategic advice 
on scientific issues relating to nutraceuticals and food 
supplements and are the most important cont ributors of 
experts to EFSA. For Malta, the national regulator is the 
Maltese Competition and Consumer Affairs Authority.6 
Inclusion of a new claim would require further detailed 
scientific testing done by the manufacturer and reviewed 
by EFSA. Since the health claims on product labels need to 
be approved by EFSA, this gives increased credibility to EU 
produced food supplements and nutraceuticals.7 
SIZE OF MARKET 
Despite the tough EU regulations on nutraceuticals, these 
didn't negatively affect the growth of the nutraceuticals 
market worldwide. Indeed. and as per the Euromonitor 
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2010 figures, it was projected that the value of the annual 
global nutraceuticals market wou Id reach US$250 billion 
by 2018 with the global nutraceuticals market by country/ 
regional share sp lit being as follows: Europe 14%, Japan 
22%, USA 30% and the rest of the World 34%.8 . In fact, the 
actual 2018 market size of nutraceuticals accounted for 
US$379 billion with an expected large growth to reach 
US$734 billion in 2026.9 
While until recently it was perceived that 
pharmaceuticals are mostly medications used to treat 
diseases, and nutraceuticals substances used to prevent 
diseases, 1° this distinction between pharmaceuticals 
and nutraceuticals has been shown to be incorrect and 
even erroneous. 
Pharmaceuticals are compounds which undergo 
thorough testing. The results form part of a dossier which 
is evaluated by regulatory authorities and if authorised, 
the pharmaceutical company benefits from patent 
protection for that product. Though not considered 
strictly pharmaceutical, herbal medicinal products are also 
regulated products. Herbal medicinal products are either 
granted marketing authorization with a well-established 
use or are registered as a traditional herbal medicinal 
product. Safety and efficacy data is mandatory and is 
derived from bibliographic data or tests carried out by the 
manufacturer. On the other hand nutraceuticals do not 
need the same extent of testing.4 
EFFICACY AND SAFETY OF NUTRACEUTICALS 
Currently, nutraceuticals are receiving a lot of interest due 
to their therapeutic promises that are being increasingly 
documented through clinical studies and more so due 
to their relatively better safety profi le in comparison 
to pharmaceuticals. However one must add that there 
are specific natural products that have a very narrow 
therapeutic window. In this case, the safety issue is linked 
to the long-standing use of these products with respect to 
pharmaceuticals. 
Nutraceutical and pharmaceutical companies are aware 
of the increased interest by the general population in 
nutraceuticals due to the benefits associated with them. 
Whenever used for an insufficiency or deficiency in a 
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vitamin, mineral or other vital molecule, most nutraceuticals 
also possess multiple therapeutic benefits apart from their 
disease prevention properties.11 
To illustrate the importance of this relatively new 
healthcare industry, international exhibitions and fairs 
are held to allow exhibitors, mainly nutraceuticals and 
food supplements companies, to show the benefits of 
their products. Visitors of these fora include healthcare 
professionals from different backgrounds as well as other 
professionals interested in the development and growth 
of the nutraceutical business. Vitafoods Europe is one of 
the most prominent annual event where the nutraceutical 
industry comes together to innovate, connect with business 
leaders and find effective solutions in the sole interest of 
the individual's health. In 2019 Vitafoods gathered more 
than 1,250 exhibi tors, 25,000 visitors and had over 110 
participating countries.12 
The list of nutraceuticals is constantly shaping up. 
Products, molecules and ingredients are being added or 
changed incessantly according to the needs of the growing 
market, opinion of healthcare professionals, feedback from 
consumers and results on efficacy and safety from ongoing 
researches. The safety of these products stem from the 
results of research and clinical trials.13 
Nutraceuticals are believed to be effective against a 
plethora of diseases and disorders e.g. cardiovascular, 
obesity, diabetes, cancer, stress, mental and neurological 
diseases, hormonal disturbances, women's health 
disorders, respiratory disorders; they may also function 
as immuno-modulators, e.g probiotics.13 While the 
mechanism of action of nutraceuticals is not fully 
understood, it is postulated that they are involved in a wide 
variety of biological processes, including the activation 
of signal tiransduction pathways, gene expression, 
cell proliferation, differentiation and preservat ion of 
mitochondrial integrity, and proliferation of human 
hematopoietic precursors. Working as antioxidants and 
improvingr antioxidant defenses is a widely accepted 
way of act ion given that reactive oxygen species and 
oxidative stress are more and more implicated in the 
etiology o f many d iseases including atherosclerosis, other 
cardiovascular diseases and cancer.10•13 
Table 1: Benefits of the mineral-bisglycinate complex" 
Characteristic of the molecular complex 
Stability (even in the stomach) 
Absence of electric charge (neutral molecule. 
The glycine molecules wrap the mineral) 
Smaller molecular size 
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MANUFACTURING AND IMPORTANCE 
OF FORMULATION 
The manufacturing process poses various challenges, 
including stability testing. The formulation used for 
specific minerals or ingredients, strains of probiotics and 
the right mixing of compatible ingredients that would not 
antagonize each other or decrease their bioavailability or 
stabili ty are all important considerations. 
The importa nee of the formulation development of 
two commonly ava ilable minerals, iron and magnesium, 
is illustrated below. Because of their low solubility, iron 
and magnesium are poorly absorbed from the intestine. 
To enhance their bioavailability, ascorbic acid may be 
included. While companies offer d ifferent nutraceuticals 
claiming to be superior in managing a condition without 
any side-effects, studies have shown that specific 
formulations ensure the best bioavailability, hence efficacy, 
with the least side-effects. One such formulation is the 
bisglycinate chelate which is made of two molecules of 
glycine that are chelated to mineral salts such as iron or 
magnesium. The mineral-bisglycinate complex is hence 
readily absorbed in the gastrointestinal tract without being 
affected by gast ric or intestinal pH. It is also minimally 
affected by the concomitant use of other minerals, and 
food intake including phytic acid-rich food, thus mimicking 
the absorption of amino acids from the gut.1'°16 
Like with other bisglycinate minerals, magnesium has 
been shown to have a better bioavailability than other 
forms of magnesium especia lly magnesium oxide. 17 The 
chelate forms of minerals are reported to have the h ighest 
absorption and bioavailability ma king it one of the most 
efficacious forms for supplementation (Table 1 ).18 
Physiological significance 
Lower interaction with food absorption inhibitors like 
phytates and oxalates; less interaction with other nutrients 
Fewer gastro-intestinal side-effects because of 
lack of dissociation of the mineral; increased 
tolerability and safety 
No need for digestive processes p rior to absorption; 
intact absorption through intestinal epithelial cells 
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What about the right recipe? When mixing multiple 
ingredients in a tablet, capsl\Jle or any other form, these 
must be compatible. Nutrients can be ingested as coated 
tablets, soft gels, capsules, sachets, effervescent tablets, 
chewables, dissolvable films, nutrition bars, etc. While 
some minerals like calcium are best delivered in tablet 
form, co-enzyme 010 or lycopene are best preserved 
when delivered in a soft gel capsule. In t he latter case t heir 
b ioavailability is significantly improved since l iquid matrix 
ingredients are designed to solubil ize rapidly even for 
poorly soluble molecules.19.20 
Incompatibility of products mixed together not only 
may lead to physical instability of the formulat ion like 
discoloration, breaking, and formation of lumps, but 
also antagonism among active ingredients or simply not 
have the required synergistic effect. A good example 
of mixing compatible ingredients is the case of vitamin 
K
2 
• also known as menaquinone · and vitamin D. This 
combination is used to help maintain healthy bones. 
These two products exert synergistic effects on bone 
metabolism. Vitamin D, also known as 1,25(0H) D
3 
is 
known to promote expression, transcription and translation 
of ost eocalcin (OC) gene. OC is secreted by osteoblasts 
and activated OC binds to calcium ions and hydroxyapatite 
crystals allowing good bone minera lization.21 On another 
hand, vitamin K2 stimulates Matrix Gia protein (MGP), 
an extensively studied extra hepatic Gia protein that is 
synthetized by chondrocytes and vascular smooth muscle 
cells. Findings in both animal and human stud ies suggest 
that after being carboxylated, hence activated, MGP 
inhibits the calcification of arteries and cartilage, while 
facil itating normal bone metabolism.22 This find ing has 
been translated clinically into improved aortic and carotid 
elasticity that could be explained by a reduced vascular 
calcification following long t erm vitamin K
2 
administration 
to post-menopausal women.23 
Finally, this fast growing non-pharmaceuticals sector 
is witnessing better acceptance from consumers as well 
as healthcare professionals. All this is based on stricter 
manufacturing requirements like ISO standards and GMP 
certification (currently this is voluntary), better knowledge 
about the mode of action o f nutraceuticals, and finally 
more clinical research that shows efficacy and safety. 
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